Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile

BACKGROUND: Clozapine is well known for its efficacy and clinical superiority compared to other antipsychotics in treatment-resistant schizophrenia (TRS). However, it is frequently underutilized worldwide because of its acute adverse events, as well as for its long-term cardiometabolic and hematolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychiatr Dis Treat
Hauptverfasser: de Filippis, Renato, Gaetano, Raffaele, Schoretsanitis, Georgios, Verde, Giuseppe, Oliveti, Cesare Anthony, Kane, John M, Segura-Garcia, Cristina, De Fazio, Pasquale
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2021
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257059/
https://ncbi.nlm.nih.gov/pubmed/34234440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S312095
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge